University of Cambridge

Institute of Therapeutic Immunology and Infectious Disease

Project summary

This project will bring together a broad range of key industry partners to achieve three inter-related ambitions. 

These are to:

  • drive therapeutic breakthroughs in immune-related diseases
  • explore new strategies for the control of globally important pathogens
  • increase the likelihood of discovering important, high-value, new medicines in the UK by enhancing interactions between academia and the pharmaceutical industry. 

The project will focus on autoimmune and inflammatory disease – for example Type 1 diabetes and inflammatory bowel disease – and the looming threat posed by antimicrobial resistance.